Seeking Alpha

InterMune (ITMN +6.1%) rallies after Wells Fargo notes French regulators gave a favorable rating...

InterMune (ITMN +6.1%) rallies after Wells Fargo notes French regulators gave a favorable rating to the company's Esbriet lung disease drug. Wells believes the rating should allow InterMune to "negotiate premium pricing" for Esbriet. (previously)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs